ROLE OF THIAZOLIDINEDIONES (TZDs) AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONISTS AND ANTAGONOSTS IN TYPE-II DIABETES MELLITUS ON ADULT MALE ALBINO RATS

ROLE OF ADIPONECTIN IN PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS

Role of β-adrenergic receptors in insulin resistance: Induction or protection?

IS APELIN A PROMISING TARGET IN DIABETES MELLITUS OF RATS: TYPE I VS. TYPE II?

THE MODULATORY EFFECT OF ANTIDIABETIC DRUGS ON THYROID FUNCTION IN DIABETIC RATS

Possible Therapeutic Role of Novel Vanadium Complexes in Diabetes MellitusAnimal Models

Role of dipeptidyl peptidase 4 in type 2 diabe tes mellitus

POSSIBLE AMELIORATIVE ROLE OF SOME COMPOUNDS ON THE SIDE EFFECTS OF ROSIGLITAZONE

PPARγ UPREGULATION MEDIATES THE ANTIDIABETIC POTENTIAL OF KAEMPFEROL IN HIGH FAT DIET/STREPTOZOTOCIN-INDUCED DIABETIC RATS

EVALUATION OF THE ANTI-ISCHEMIC EFFECT OF THE PPARy AGONIST, (ROSIGLITAZONE) IN PERMANENT FOCAL CEREBRAL ISCHEMIA IN DIABETIC RATS.